T1D and T2D insulin-treated patients present the same goals for performing SMBG [30] and it has been demonstrated that more frequent measurements of SMBG were associated with better metabolic control in both T1D and T2D insulin-treated patients [60]. This evidence concerns the gene INS and type 2 diabetes mellitus.